Related Experiment Videos

Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells

A Inga1, R Iannone, P Campomenosi

  • 1Centre for the Study of Tumors of Environmental Origin-Mutagenesis Laboratory, National Institute for Research on Cancer IST, Genova, Italy.

Cancer Research
|October 15, 1995
PubMed

Insights

Chloroethyl-cyclohexyl-nitrosourea (CCNU) induces specific DNA mutations in kidney cells. The study reveals CCNU

Area of Science:

  • Molecular Biology
  • Genetics
  • Toxicology

Background:

  • Chloroethyl-cyclohexyl-nitrosourea (CCNU) is a chemotherapeutic agent implicated in therapy-related leukemias.
  • Understanding the mutagenic mechanisms of CCNU is crucial for assessing its risks.

Purpose of the Study:

  • To determine the mutation spectra induced by CCNU in African green monkey kidney cells (CV1).
  • To investigate the DNA sequence context and repair mechanisms influencing CCNU-induced mutations.

Main Methods:

  • Utilized the pZ189 shuttle vector system to analyze CCNU-induced mutations.
  • Sequenced plasmids from independent clones to identify mutations in the supF gene.
  • Analyzed mutation types, frequencies, and hot spots at different CCNU concentrations (3 mM and 6 mM).

Main Results:

  • Identified GC-targeted base pair substitutions as the majority of CCNU-induced mutations.
  • Observed significantly higher AT-targeted mutations and distinct mutational spectra at 3 mM and 6 mM CCNU.
  • Located specific mutation hot spots (e.g., 5'-GGG-3') influenced by CCNU concentration and DNA sequence context.

Conclusions:

  • Results support the hypothesis that O6-alkylguanine and O4-alkylthymine/N3-alkyladenine contribute to CCNU-induced GC and AT mutations, respectively.
  • Suggests that DNA repair efficiency for O6-alkylguanine is influenced by the surrounding DNA sequence in CV1 cells.
  • The study defines the "mutational fingerprint" of CCNU, providing insights into its genotoxicity.

Related Concept Videos